Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009. - Wikidata - wikimedia - TriplyDB

Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009.

Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009.

http://www.wikidata.org/entity/Q30408429

about

Safety and efficacy of peramivir for influenza treatment Prolonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferrets Resistance mutation R292K is induced in influenza A(H6N2) virus by exposure of infected mallards to low levels of oseltamivir Antivirals in the 2009 pandemic--lessons and implications for future strategies.Oseltamivir use and outcomes during the 2009 influenza A H1N1 pandemic in Taiwan.Trends in antiviral therapy of adults hospitalized with influenza in Canada since the end of the 2009 pandemic.Respiratory viral infections among hospitalized adults: experience of a single tertiary healthcare hospital.Antiviral treatment among older adults hospitalized with influenza, 2006-2012 The US Influenza Hospitalization Surveillance Network Increased Antiviral Treatment Among Hospitalized Children and Adults With Laboratory-Confirmed Influenza, 2010-2015 Public health management of antiviral drugs during the 2009 H1N1 influenza pandemic: a survey of local health departments in California Impact of antiviral treatment and hospital admission delay on risk of death associated with 2009 A/H1N1 pandemic influenza in Mexico.Risk factors for mortality among 2009 A/H1N1 influenza hospitalizations in Maricopa County, Arizona, April 2009 to March 2010 Impact of medical and behavioural factors on influenza-like illness, healthcare-seeking, and antiviral treatment during the 2009 H1N1 pandemic: USA, 2009-2010.Oseltamivir Use Among Children and Adults Hospitalized With Community-Acquired Pneumonia Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season Influenza antiviral treatment in spinal cord injury patients, 2007-2010 Survey of influenza and other respiratory viruses diagnostic testing in US hospitals, 2012-2013 Optimizing antiviral therapy for influenza: understanding the evidence.Phase 2 Randomized Trial of the Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Virus Challenge Model.Benefit of Early Initiation of Influenza Antiviral Treatment to Pregnant Women Hospitalized With Laboratory-Confirmed Influenza.A cluster of patients infected with I221V influenza b virus variants with reduced oseltamivir susceptibility--North Carolina and South Carolina, 2010-2011.Patients hospitalized with laboratory-confirmed influenza during the 2010-2011 influenza season: exploring disease severity by virus type and subtype.Editorial commentary. "Late" treatment with neuraminidase inhibitors for severely ill patients with influenza: better late than never?

P2860

Q27027408-58DDF219-993C-42A7-B298-6B2F78AE9B29 Q27334946-43B701FD-CC0E-43C4-968E-C25225CE78EF Q28535274-D3303885-C45F-438A-B5DE-DCC6D8C62632 Q30219151-E40B594E-98A2-4F04-A946-7948929F142E Q30352057-499E971C-2159-473F-A362-BEC7A17F0C14 Q30357688-CB66C72F-0AD6-4C02-AC95-0AD10FD57082 Q30358632-0A75B6AB-7E43-4BF9-8AEF-31A10ADC5BEF Q30373020-52F23032-17C1-4DD2-9DAE-D92A5CF6DC31 Q30378144-2A37067A-CDEE-445A-87D3-798C40B874F4 Q30396792-20AB8B28-539A-4149-9B5D-678914F83D93 Q30412191-DB96F237-5EF7-49D7-AD07-4C15E2AB6A34 Q30415719-3802F588-3CA6-495D-8952-7EEEC9299EAC Q30419774-7C66FEC9-BC01-4838-81D4-32A64786C1CC Q30428627-E71A8B1E-EB1C-4B13-BC8E-B19495D5BCFB Q33629039-9661616B-2FC0-4CB0-8496-FD8FE76FDD32 Q34354261-E924DEB2-A84E-439F-9B55-A2C82F5E33E2 Q34947758-792B72AC-317B-4E43-ABBC-842C0127A2E5 Q38299002-A824A62A-91DC-4E5F-ADBD-2DA24325FF49 Q38361244-50804ABB-BEF4-4B71-B874-0C400DF9E696 Q40083222-092E883B-5F6B-4D26-A5BB-A96D559E8160 Q40779930-6D8D1BF8-5D66-47CB-B2FD-2E1D7600AFFD Q42282531-0E80695D-DDA6-4E3B-B136-10DCEFCE3E6D Q42283189-1D1D41A8-2935-42DE-BBC8-BE08655ED32C Q43865089-5A1E3762-D740-45D5-86B4-08FD49CCF331

P2860

Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009.

http://www.wikidata.org/entity/Q30408429

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Description of antiviral treat ...... mic: United States, 2005-2009.

@ast

Description of antiviral treat ...... mic: United States, 2005-2009.

@en

type

label

Description of antiviral treat ...... mic: United States, 2005-2009.

@ast

Description of antiviral treat ...... mic: United States, 2005-2009.

@en

prefLabel

Description of antiviral treat ...... mic: United States, 2005-2009.

@ast

Description of antiviral treat ...... mic: United States, 2005-2009.

@en

P1433

Q30408429-92A6C84E-B72B-40C1-9216-AD78472B62AD

P1476

Q30408429-10979D20-9F47-45E9-BCE2-CC8711EB731C

P2093

Q30408429-033D0753-4EED-4A18-BC87-532BEC947F8A

Q30408429-099AD995-423C-4D1B-A3FA-90FB4FDCF7A4

Q30408429-117A80D8-9982-4BB5-AA86-5CBED58AA4D6

Q30408429-5BEE2BC7-2129-4487-942A-796E1EB96EF2

Q30408429-6AF3AB85-B466-4BC8-B62D-15D364535B8A

Q30408429-A7D23BC6-D787-4ADD-BE18-832F42DF414C

Q30408429-B5C40CF3-21A1-4614-9FE4-ADD6E9663765

Q30408429-B8EC3051-A2F8-40BB-98A4-28096C8A7DF7

Q30408429-C8417074-F14A-4DDF-81C9-DCCF7FDDAA46

Q30408429-CDD44E09-869C-46C0-89D6-0AA5D96F6BA9

P304

Q30408429-4EDD7F26-FEFB-4BFC-9D16-D6044DD13D2C

P31

Q30408429-337C2A86-54D2-4F01-B659-0EFA5AD0472A

P356

Q30408429-1597B058-A74F-4012-AB32-CC52D566BFDB

P407

Q30408429-D6AB7CE6-BFD7-4BBB-A67A-74D80254BDE5

P433

Q30408429-FA1E49B6-6C59-42F6-B9D4-A1763D7D46C0

P478

Q30408429-D2015A84-62D8-462E-A53C-0296A0AF73B4

P50

Q30408429-6765E861-30EE-430D-AEDA-5F4265295C56

Q30408429-7942D7FF-97B1-48AD-B157-03003819C8A0

Q30408429-98E08FA5-CF0D-4126-8CB5-A0B433858EE5

Q30408429-BAC7ABC7-A49F-423C-BE91-012C94F28B2C

Q30408429-FC836F05-2B70-4E90-9554-3920BF1C7EFE

P577

Q30408429-13755E15-2214-40BF-B261-6900E68C0582

P5875

Q30408429-94DF185B-D9D1-4F8E-B472-DB4A80521010

P698

Q30408429-9EC72D95-29F9-4E5B-A5AA-2DE336F3AF53

P921

Q30408429-70B947FD-A88A-43E5-82EF-D1B283E570BD

Q30408429-CA76B79E-3587-45F7-A23A-D2A492525760

P356

P1433

The Journal of Infectious Diseases

P1476

Description of antiviral treat ...... mic: United States, 2005-2009.

@en

P2093

Alejandro Perez

http://www.w3.org/2001/XMLSchema#string

Ann Thomas

http://www.w3.org/2001/XMLSchema#string

Arthur Reingold

http://www.w3.org/2001/XMLSchema#string

Craig Morin

http://www.w3.org/2001/XMLSchema#string

Emily B Hancock

http://www.w3.org/2001/XMLSchema#string

Joan Baumbach

http://www.w3.org/2001/XMLSchema#string

Kathryn Arnold

http://www.w3.org/2001/XMLSchema#string

Ken Gershman

http://www.w3.org/2001/XMLSchema#string

Laurie Kamimoto

http://www.w3.org/2001/XMLSchema#string

Nancy M Bennett

http://www.w3.org/2001/XMLSchema#string

P304

1848-1856

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INFDIS/JIR648

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

204

http://www.w3.org/2001/XMLSchema#string

P50

Kimberly Yousey-Hindes

William Schaffner

P577

2011-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51731910

http://www.w3.org/2001/XMLSchema#string

P698

22013219

http://www.w3.org/2001/XMLSchema#string

P921

hospitalization